Verastem (VSTM) Stock Forecast & Price Target

Compare

1,906 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VSTM Analyst Ratings

Strong Buy

7 Buy

0 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Verastem

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VSTM Stock 12 Month Forecast

Average Price Target

$15.67

▲(102.72% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is $15.67 with a high forecast of $20.00 and a low forecast of $13.00. The average price target represents a 102.72% change from the last price of $7.73.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","6":"$6","11":"$11","16":"$16","21":"$21"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,6,11,16,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.08,7.150769230769231,8.221538461538461,9.292307692307691,10.363076923076923,11.433846153846154,12.504615384615384,13.575384615384614,14.646153846153846,15.716923076923075,16.787692307692307,17.85846153846154,18.92923076923077,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.08,6.817692307692308,7.555384615384615,8.293076923076923,9.03076923076923,9.768461538461539,10.506153846153847,11.243846153846153,11.981538461538461,12.71923076923077,13.456923076923076,14.194615384615384,14.932307692307692,{"y":15.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.08,6.612307692307692,7.144615384615385,7.676923076923076,8.20923076923077,8.741538461538461,9.273846153846154,9.806153846153846,10.338461538461537,10.87076923076923,11.403076923076924,11.935384615384615,12.467692307692307,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.25,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.43,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.5,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.82,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.92,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.52,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.17,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.6,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.82,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.43,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.02,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.29,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.08,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$20.00

Average Price Target$15.67

Lowest Price Target$13.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Graig Suvannavejh

Mizuho Securities

$16→$14

Buy

81.11%

Upside

Reiterated

08/15/25

we lower our PT $14 (vs. $16 prior) ... we stay Outperform-rated on VSTM

Justin Zelin

BTIG

$20

Buy

158.73%

Upside

Reiterated

08/14/25

BTIG Reaffirms Their Buy Rating on Verastem (VSTM)we reiterate our Buy rating and $20 PT.

Sean Lee CFA

H.C. Wainwright

$14

Buy

81.11%

Upside

Reiterated

08/08/25

Verastem's Promising Market Expansion and Financial Health Drive Buy Rating

Michael Schmidt

Guggenheim

$14

Buy

81.11%

Upside

Reiterated

08/07/25

Guggenheim Remains a Buy on Verastem (VSTM)Initial LGSOC sales and early launch momentum drive our reiteration of a Buy with a $14 PT.

Leonid Timashev

RBC Capital

$12→$13

Buy

68.18%

Upside

Reiterated

08/07/25

RBC Capital Keeps Their Buy Rating on Verastem (VSTM)

Kelly Shi

Jefferies

$19

Buy

145.80%

Upside

Reiterated

06/04/25

Verastem's Strategic Growth and Promising Clinical Data Drive Buy Rating

Unknown Analyst

Cantor Fitzgerald

Not Ranked

Cantor Fitzgerald

―

Buy

―

Reiterated

06/03/25

Verastem (VSTM) Receives a Buy from Cantor Fitzgerald

James Molloy

Alliance Global Partners

$14

Buy

81.11%

Upside

Reiterated

05/14/25

Alliance Global Partners Sticks to Its Buy Rating for Verastem (VSTM)

Kalpit Patel

B.Riley Financial

$12→$13

Buy

68.18%

Upside

Reiterated

05/09/25

Verastem price target raised to $13 from $12 at B. RileyVerastem price target raised to $13 from $12 at B. Riley

Dex Genotek

TR | OpenAI - 4o

―

Hold

―

Reiterated

04/26/25

AI Generated ArticleAI Generated Article

Sean Lee

Citi

$7→$10

Buy

29.37%

Upside

Reiterated

03/24/25

Verastem's Promising Financial Outlook and Strategic Advancements Drive Buy Rating

Srikripa Devarakonda

Truist Financial

$15

Buy

94.05%

Upside

Assigned

10/18/24

Verastem Stock: Buy Rating Amid Market Overreaction and Promising Commercial Potential

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Graig Suvannavejh

Mizuho Securities

$16→$14

Buy

81.11%

Upside

Reiterated

08/15/25

we lower our PT $14 (vs. $16 prior) ... we stay Outperform-rated on VSTM

Justin Zelin

BTIG

$20

Buy

158.73%

Upside

Reiterated

08/14/25

BTIG Reaffirms Their Buy Rating on Verastem (VSTM)we reiterate our Buy rating and $20 PT.

Sean Lee CFA

H.C. Wainwright

$14

Buy

81.11%

Upside

Reiterated

08/08/25

Verastem's Promising Market Expansion and Financial Health Drive Buy Rating

Michael Schmidt

Guggenheim

$14

Buy

81.11%

Upside

Reiterated

08/07/25

Guggenheim Remains a Buy on Verastem (VSTM)Initial LGSOC sales and early launch momentum drive our reiteration of a Buy with a $14 PT.

Leonid Timashev

RBC Capital

$12→$13

Buy

68.18%

Upside

Reiterated

08/07/25

RBC Capital Keeps Their Buy Rating on Verastem (VSTM)

Kelly Shi

Jefferies

$19

Buy

145.80%

Upside

Reiterated

06/04/25

Verastem's Strategic Growth and Promising Clinical Data Drive Buy Rating

Unknown Analyst

Cantor Fitzgerald

Not Ranked

Cantor Fitzgerald

―

Buy

―

Reiterated

06/03/25

Verastem (VSTM) Receives a Buy from Cantor Fitzgerald

James Molloy

Alliance Global Partners

$14

Buy

81.11%

Upside

Reiterated

05/14/25

Alliance Global Partners Sticks to Its Buy Rating for Verastem (VSTM)

Kalpit Patel

B.Riley Financial

$12→$13

Buy

68.18%

Upside

Reiterated

05/09/25

Verastem price target raised to $13 from $12 at B. RileyVerastem price target raised to $13 from $12 at B. Riley

Dex Genotek

TR | OpenAI - 4o

―

Hold

―

Reiterated

04/26/25

AI Generated ArticleAI Generated Article

Sean Lee

Citi

$7→$10

Buy

29.37%

Upside

Reiterated

03/24/25

Verastem's Promising Financial Outlook and Strategic Advancements Drive Buy Rating

Srikripa Devarakonda

Truist Financial

$15

Buy

94.05%

Upside

Assigned

10/18/24

Verastem Stock: Buy Rating Amid Market Overreaction and Promising Commercial Potential

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Verastem

1 Month

xxx

Success Rate

10/13 ratings generated profit

Average Return

+4.79%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 76.92% of your transactions generating a profit, with an average return of +4.79% per trade.

3 Months

xxx

Success Rate

7/13 ratings generated profit

Average Return

+10.54%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +10.54% per trade.

1 Year

Graig SuvannavejhMizuho Securities

Success Rate

9/13 ratings generated profit

Average Return

+36.94%

reiterated a buy rating yesterday

Copying Graig Suvannavejh's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +36.94% per trade.

2 Years

xxx

Success Rate

9/13 ratings generated profit

Average Return

+44.91%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 69.23% of your transactions generating a profit, with an average return of +44.91% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VSTM Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, VSTM has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VSTM average Analyst price target in the past 3 months is 15.67.

Each month's total comprises the sum of three months' worth of ratings.

VSTM Financial Forecast

VSTM Earnings Forecast

Next quarter’s earnings estimate for VSTM is -$0.59 with a range of -$0.74 to -$0.43. The previous quarter’s EPS was -$0.39. VSTM beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year VSTM has Outperformed its overall industry.

VSTM Sales Forecast

Next quarter’s sales forecast for VSTM is $5.66M with a range of $3.56M to $9.30M. The previous quarter’s sales results were $2.14M. VSTM beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 54.41% of the time in the same period. In the last calendar year VSTM has Outperformed its overall industry.

VSTM Stock Forecast FAQ

What is VSTM’s average 12-month price target, according to analysts?

Based on analyst ratings, Verastem’s 12-month average price target is 15.67.

What is VSTM’s upside potential, based on the analysts’ average price target?

Verastem has 102.72% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is VSTM a Buy, Sell or Hold?

Verastem has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.

What is Verastem’s price target?

The average price target for Verastem is 15.67. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $13.00. The average price target represents 102.72% Increase from the current price of $7.73.

What do analysts say about Verastem?

Verastem’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of VSTM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Verastem (VSTM) Stock Forecast & Price Target

VSTM Analyst Ratings

VSTM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Verastem

VSTM Analyst Recommendation Trends

VSTM Financial Forecast

VSTM Earnings Forecast

VSTM Sales Forecast

VSTM Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts